ZNTL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.60%

Insider Buying (Last 12 Months): $148,800.00

Insider Selling (Last 12 Months): $180,656.29

Zentalis Pharmaceuticals Insider Trading History Chart

Zentalis Pharmaceuticals Share Price & Price History

^$1.29

▼ -0.07 (-5.17%)

As of 04/3/2025 05:00 PM ET

Days: 30 | 90 | 365

Zentalis Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/6/2025	Ingmar Bruns	Insider	Buy	20,000	$2.28	$45,600.00	36,629
2/3/2025	Vincent Vultaggio	Insider	Sell	2,615	$1.71	$4,471.65	189,826
1/31/2025	Jan Skvarka	Director	Buy	60,000	$1.72	$103,200.00	149,551
1/2/2025	Mark Lackner	Insider	Sell	4,411	$3.12	$13,762.32	191,317
10/4/2024	Vincent Vultaggio	Insider	Sell	1,603	$3.18	$5,097.54	33,855
5/31/2024	Cam Gallagher	CFO	Sell	9,597	$11.98	$114,972.06	633,680
5/9/2024	Diana Hausman	Insider	Sell	3,356	$12.62	$42,352.72	373,876
2/12/2024	Cam Gallagher	President	Sell	1,173	$11.44	$13,419.12	643,277
2/12/2024	Melissa B. Epperly	CFO	Sell	2,573	$11.44	$29,435.12	451,449
11/13/2023	Kimberly Blackwell	CEO	Buy	5,000	$10.29	$51,450.00	254,800
11/10/2023	David Michael Johnson	Director	Buy	17,000	$9.88	$167,960.00	144,389
10/4/2023	Carrie Brownstein	Insider	Sell	10,628	$19.50	$207,246.00	105,685
10/4/2023	Melissa B. Epperly	CFO	Sell	5,482	$19.50	$106,899.00	387,691
9/11/2023	Jan Skvarka	Director	Sell	5,000	$25.05	$125,250.00	47,970
6/20/2023	Matrix Capital Management Comp	Major Shareholder	Buy	4,760,000	$22.66	$107,861,600.00	13,959,973
5/31/2023	Cam Gallagher	President	Sell	27,768	$26.27	$729,465.36	463,502
5/26/2023	Kevin D. Bunker	Insider	Sell	80,000	$30.02	$2,401,600.00	15,000
2/13/2023	Cam Gallagher	President	Sell	3,332	$20.42	$68,039.44	499,771
2/13/2023	Kevin D. Bunker	Insider	Sell	3,807	$20.42	$77,738.94	871,657
2/13/2023	Melissa B. Epperly	CFO	Sell	2,624	$20.42	$53,582.08	397,275
2/6/2023	Cam Gallagher	President	Sell	10,000	$22.27	$222,700.00	503,103
1/17/2023	Cam Gallagher	President	Sell	10,000	$24.15	$241,500.00	352,011
1/5/2023	Cam Gallagher	President	Sell	10,000	$21.02	$210,200.00	362,011
11/15/2022	Cam Gallagher	President	Sell	12,500	$22.77	$284,625.00	372,011
11/7/2022	Cam Gallagher	President	Sell	12,500	$23.67	$295,875.00	396,885
10/17/2022	Cam Gallagher	President	Sell	12,500	$23.51	$293,875.00	409,385
10/5/2022	Cam Gallagher	President	Sell	12,500	$22.32	$279,000.00	431,885
9/15/2022	Cam Gallagher	President	Sell	12,500	$25.26	$315,750.00	454,385
7/20/2022	Kevin D. Bunker	COO	Sell	5,000	$30.00	$150,000.00	100,000
7/13/2022	Kevin D. Bunker	COO	Sell	1,710	$30.02	$51,334.20	108,290
7/5/2022	Kevin D. Bunker	COO	Sell	25,000	$30.07	$751,750.00	110,000
4/11/2022	Kevin D. Bunker	COO	Sell	5,000	$30.55	$152,750.00	135,000
4/5/2022	Cam Gallagher	Director	Sell	10,000	$50.48	$504,800.00	355,813
4/4/2022	Anthony Y. Sun	CEO	Sell	10,471	$48.50	$507,843.50	1,175,589
4/4/2022	Melissa B. Epperly	CFO	Sell	17,080	$50.09	$855,537.20	247,414

See Full Table

SEC Filings (Institutional Ownership Changes) for Zentalis Pharmaceuticals (NASDAQ:ZNTL)

Institutional Buying and Selling by Quarter

Zentalis Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/17/2025	Wealth Enhancement Advisory Services LLC	200,113	$0.61M	0.0%	+194.7%	0.281%
2/17/2025	Woodline Partners LP	530,582	$1.61M	0.0%	-49.7%	0.745%
2/17/2025	Vident Advisory LLC	14,735	$45K	0.0%	N/A	0.021%
2/17/2025	Squarepoint Ops LLC	50,756	$0.15M	0.0%	-55.9%	0.071%
2/17/2025	Two Sigma Investments LP	616,800	$1.87M	0.0%	-32.1%	0.866%
2/17/2025	Two Sigma Advisers LP	889,700	$2.70M	0.0%	-22.6%	1.249%
2/17/2025	State of Wyoming	34,716	$0.11M	0.0%	+124.6%	0.049%
2/17/2025	Point72 Asia Singapore Pte. Ltd.	17,115	$52K	0.0%	N/A	0.024%
2/17/2025	ProShare Advisors LLC	16,094	$49K	0.0%	-46.3%	0.023%
2/17/2025	MPM Bioimpact LLC	1,106,851	$3.35M	0.5%	-24.5%	1.553%
2/17/2025	Nuveen Asset Management LLC	641,407	$1.94M	0.0%	+35.2%	0.900%
2/17/2025	Millennium Management LLC	957,563	$2.90M	0.0%	+8.1%	1.344%
2/17/2025	Integral Health Asset Management LLC	1,050,000	$3.18M	0.3%	N/A	1.473%
2/17/2025	Jacobs Levy Equity Management Inc.	232,058	$0.70M	0.0%	N/A	0.326%
2/17/2025	Graham Capital Management L.P.	57,946	$0.18M	0.0%	+37.4%	0.081%
2/17/2025	Deutsche Bank AG	42,804	$0.13M	0.0%	+34.1%	0.060%
2/17/2025	D. E. Shaw & Co. Inc.	1,239,459	$3.76M	0.0%	+9.8%	1.739%
2/17/2025	Corton Capital Inc.	10,412	$32K	0.0%	N/A	0.015%
2/17/2025	Cubist Systematic Strategies LLC	180,224	$0.55M	0.0%	N/A	0.253%
2/17/2025	Bridgeway Capital Management LLC	175,000	$0.53M	0.0%	N/A	0.246%
2/17/2025	Brevan Howard Capital Management LP	26,351	$80K	0.0%	+70.6%	0.037%
2/17/2025	Captrust Financial Advisors	10,783	$33K	0.0%	N/A	0.015%
2/17/2025	Balyasny Asset Management L.P.	57,592	$0.18M	0.0%	-16.1%	0.081%
2/17/2025	Bank of America Corp DE	215,999	$0.65M	0.0%	-72.1%	0.303%
2/17/2025	BNP Paribas Financial Markets	176,292	$0.53M	0.0%	N/A	0.247%
2/17/2025	Ameriprise Financial Inc.	146,673	$0.44M	0.0%	N/A	0.206%
2/17/2025	Algert Global LLC	51,100	$0.16M	0.0%	-30.1%	0.072%
2/17/2025	Almitas Capital LLC	1,626,896	$4.93M	1.1%	+69.3%	2.283%
2/14/2025	Boxer Capital Management LLC	450,000	$1.36M	0.1%	N/A	0.631%
2/14/2025	Jane Street Group LLC	323,514	$0.98M	0.0%	+100.7%	0.454%
2/14/2025	Northern Trust Corp	484,738	$1.47M	0.0%	+2.2%	0.680%
2/14/2025	Quarry LP	53,500	$0.16M	0.0%	+256.7%	0.075%
2/14/2025	Decheng Capital LLC	2,338,095	$7.08M	1.5%	-24.8%	3.281%
2/14/2025	Oxford Asset Management LLP	17,134	$52K	0.0%	N/A	0.024%
2/14/2025	Virtus ETF Advisers LLC	22,713	$69K	0.0%	+134.6%	0.032%
2/14/2025	Nebula Research & Development LLC	14,167	$43K	0.0%	-51.5%	0.020%
2/14/2025	Voya Investment Management LLC	57,017	$0.17M	0.0%	+14.1%	0.080%
2/14/2025	Price T Rowe Associates Inc. MD	979,855	$2.97M	0.0%	-5.5%	1.375%
2/14/2025	Harvest Investment Services LLC	48,680	$0.15M	0.0%	N/A	0.068%
2/14/2025	MetLife Investment Management LLC	22,971	$70K	0.0%	-32.6%	0.032%
2/13/2025	Zacks Investment Management	22,340	$68K	0.0%	N/A	0.031%
2/13/2025	Walleye Capital LLC	193,709	$0.59M	0.0%	N/A	0.272%
2/13/2025	XTX Topco Ltd	122,988	$0.37M	0.0%	-36.6%	0.173%
2/13/2025	Barclays PLC	117,395	$0.36M	0.0%	+55.7%	0.165%
2/13/2025	Raymond James Financial Inc.	22,440	$68K	0.0%	N/A	0.031%
2/13/2025	Renaissance Technologies LLC	539,345	$1.63M	0.0%	-3.2%	0.757%
2/13/2025	Cerity Partners LLC	12,922	$40K	0.0%	N/A	0.018%
2/13/2025	Federated Hermes Inc.	493,982	$1.50M	0.0%	+2.2%	0.693%
2/13/2025	Russell Investments Group Ltd.	60,021	$0.18M	0.0%	+169.2%	0.084%
2/13/2025	Dynamic Technology Lab Private Ltd	17,490	$53K	0.0%	N/A	0.025%
2/13/2025	Wells Fargo & Company MN	34,609	$0.11M	0.0%	+26.8%	0.049%
2/12/2025	Geode Capital Management LLC	1,312,964	$3.98M	0.0%	+1.6%	1.842%
2/12/2025	Franklin Resources Inc.	106,748	$0.32M	0.0%	N/A	0.150%
2/12/2025	JPMorgan Chase & Co.	859,710	$2.61M	0.0%	+75.7%	1.206%
2/11/2025	Prudential Financial Inc.	12,840	$39K	0.0%	N/A	0.018%
2/11/2025	Sei Investments Co.	35,320	$0.11M	0.0%	N/A	0.050%
2/11/2025	Virtu Financial LLC	24,973	$76K	0.0%	N/A	0.035%
2/10/2025	Thrivent Financial for Lutherans	70,641	$0.21M	0.0%	+155.9%	0.099%
2/10/2025	Primecap Management Co. CA	1,520,630	$4.61M	0.0%	+1.5%	2.134%
2/10/2025	Connor Clark & Lunn Investment Management Ltd.	345,039	$1.05M	0.0%	+50.6%	0.484%
2/7/2025	Meriwether Wealth & Planning LLC	21,640	$66K	0.0%	N/A	0.030%
2/6/2025	Raymond James Financial Inc.	22,440	$68K	0.0%	N/A	0.031%
2/6/2025	Charles Schwab Investment Management Inc.	497,362	$1.51M	0.0%	+22.4%	0.698%
2/5/2025	Anfield Capital Management LLC	129,318	$0.39M	0.1%	+100.0%	0.181%
2/4/2025	Bank of New York Mellon Corp	162,935	$0.49M	0.0%	-6.0%	0.229%
2/3/2025	Ieq Capital LLC	15,115	$46K	0.0%	N/A	0.021%
1/29/2025	Values First Advisors Inc.	36,032	$0.11M	0.1%	-51.7%	0.051%
1/29/2025	Savant Capital LLC	23,893	$72K	0.0%	N/A	0.034%
1/17/2025	SG Americas Securities LLC	56,389	$0.17M	0.0%	+115.6%	0.079%
12/26/2024	JPMorgan Chase & Co.	489,199	$1.80M	0.0%	-1.3%	0.686%
11/19/2024	Barclays PLC	75,395	$0.28M	0.0%	+18.5%	0.106%
11/16/2024	Geode Capital Management LLC	1,292,100	$4.76M	0.0%	-3.2%	1.813%
11/15/2024	Barclays PLC	75,395	$0.28M	0.0%	+18.5%	0.106%
11/15/2024	Y Intercept Hong Kong Ltd	12,303	$45K	0.0%	-88.2%	0.017%
11/15/2024	XTX Topco Ltd	194,062	$0.71M	0.1%	+8.7%	0.272%
11/15/2024	Jane Street Group LLC	161,193	$0.59M	0.0%	-6.8%	0.226%
11/15/2024	State Street Corp	1,246,613	$4.59M	0.0%	-59.2%	1.749%
11/15/2024	Quarry LP	15,000	$55K	0.0%	N/A	0.021%
11/15/2024	Paloma Partners Management Co	10,024	$37K	0.0%	N/A	0.014%
11/15/2024	Erste Asset Management GmbH	9,800	$37K	0.0%	N/A	0.014%
11/14/2024	PDT Partners LLC	107,159	$0.39M	0.0%	+166.0%	0.151%
11/14/2024	Verition Fund Management LLC	1,504,320	$5.54M	0.0%	+172.1%	2.115%
11/14/2024	Capstone Investment Advisors LLC	13,066	$48K	0.0%	N/A	0.018%
11/14/2024	Martingale Asset Management L P	24,712	$91K	0.0%	N/A	0.035%
11/13/2024	FMR LLC	5,075,837	$18.68M	0.0%	-41.5%	7.138%
11/12/2024	49 Wealth Management LLC	22,558	$83K	0.0%	+81.7%	0.032%
11/12/2024	Charles Schwab Investment Management Inc.	406,210	$1.50M	0.0%	-13.3%	0.571%
11/9/2024	Primecap Management Co. CA	1,498,030	$5.51M	0.0%	+21.6%	2.107%
11/9/2024	Intech Investment Management LLC	20,407	$75K	0.0%	N/A	0.029%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	229,138	$0.84M	0.0%	+126.3%	0.322%
11/5/2024	Aigen Investment Management LP	11,054	$41K	0.0%	N/A	0.016%
11/5/2024	GSA Capital Partners LLP	608,585	$2.24M	0.2%	+138.5%	0.856%
11/4/2024	Los Angeles Capital Management LLC	59,805	$0.22M	0.0%	-28.6%	0.084%
11/1/2024	Carson Advisory Inc.	24,570	$90K	0.1%	+55.8%	0.035%
10/25/2024	China Universal Asset Management Co. Ltd.	13,676	$50K	0.0%	+63.9%	0.019%
10/24/2024	Wealth Enhancement Advisory Services LLC	67,893	$0.25M	0.0%	+44.3%	0.095%
10/10/2024	Exchange Traded Concepts LLC	45,506	$0.17M	0.0%	+195.3%	0.064%
10/3/2024	SG Americas Securities LLC	26,149	$96K	0.0%	+84.8%	0.037%
8/16/2024	Algert Global LLC	19,119	$78K	0.0%	N/A	0.027%
8/15/2024	Decheng Capital LLC	3,070,442	$12.56M	3.8%	+46.2%	4.323%

Data available starting January 2016

See Full Table

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its products candidatures include the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase for the treatment of inhibitor for advanced solid tumors and hematological malignancies; in Phase 2 clinical trial as a monotherapy for the treatment of uterine serous carcinoma indications; Phase 2 clinical trial in Cyclin E1 driven high-grade serous ovarian cancer, fallopian tube, or primary peritoneal cancer; Phase 1/2 clinical trial in combination with PARPi for platinum-resistant ovarian cancer; Phase 1b clinical trial in combination with chemotherapy in platinum-resistant ovarian, and peritoneal or fallopian tube cancer; Phase 1/2 clinical trial in combination with chemotherapy in relapsed or refractory osteosarcoma; Phase 1/2 clinical trial with encorafenib and cetuximab for mutant metastatic colorectal cancer; and Phase 1/2 clinical trial in combination with chemotherapy in pancreatic cancer. The company's products pipeline also includes ZN-d5, an oral small molecule inhibitor of B-cell lymphoma 2, for hematological malignancies and related disorders; and BCL-xL heterobifunctional degrader, a member of the anti-apoptotic BCL-2 proteins, for solid tumors and hematological malignancies. Zentalis Pharmaceuticals, Inc. has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC; Pfizer, Inc.; Zentera Therapeutics; Dana-Farber; and GlaxoSmithKline plc. The company was incorporated in 2014 and is headquartered in New York, New York.

Today's Range

Now: $1.29

$1.21

$1.30

50 Day Range

MA: $1.97

$1.29

$2.53

52 Week Range

Now: $1.29

$1.21

$16.21

Volume

645,349 shs

Average Volume

1,527,275 shs

Market Capitalization

$92.28 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.75

Who are the company insiders with the largest holdings of Zentalis Pharmaceuticals?: Zentalis Pharmaceuticals' top insider investors include:
Matrix Capital Management Comp (Major Shareholder)
Cam Gallagher (President)
Cam Gallagher (CFO)
Melissa B Epperly (CFO)
Diana Hausman (Insider)
Kimberly Blackwell (CEO)
Mark Lackner (Insider)
Vincent Vultaggio (Insider)
Jan Skvarka (Director)
David Michael Johnson (Director)
Carrie Brownstein (Insider)
Ingmar Bruns (Insider)
Kevin D Bunker (Insider)
Learn More about top insider investors at Zentalis Pharmaceuticals.